Comparison of metoclopramide with Ondansetron for Treating Nausea

A Comparison of metoclopramide with Ondansetron for Treating Nausea in Adult Patient

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180717040509N1

Enrollment

150

Registered

2018-08-02

Start date

2016-01-21

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nause. Nausea

Interventions

Intervention 1: ?First Intervention group: Ondansetron 4mg / 2ml, manufactured by Tehran Chemistry Co., is prepared in 2ml syringes. Drug injections will be given by a nurse with the help of angiogene

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with Nausea sign

Exclusion criteria

Exclusion criteria: Age under 18 years Pregnant patients Patients with mental and physical disabilities Patients with a history of allergy to study drugs Patients with systolic blood pressure less than 90mmHg Receive an anti-nausea medicine in the last 24 hours

Design outcomes

Primary

Measure	Time frame
Severity of nausea based on Visual ?Analog Scale. Timepoint: At the beginning of the study (before the injection) and 30 minutes after the injection of the drug. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Jahaniyan

Sari University of Medical Sciences

sheilaml442@gmail.com+98 11221700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026